img

Global Central Nervous System Drugs Market Research Report 2024

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Central Nervous System Drugs Market Research Report 2024

The central nervous system (CNS) is the part of thenervous system consisting of the brain and spinal cord. In this report, we study the drugs for central nervous system disease.
According to Mr Accuracy reports new survey, global Central Nervous System Drugs market is projected to reach US$ 186780 million in 2029, increasing from US$ 115260 million in 2022, with the CAGR of 7.5% during the period of 2024 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Central Nervous System Drugs market research.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Central Nervous System Drugs market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Biogen
Pfizer
Teva
Novartis
Johnson & Johnson
EliLilly
Otsuka
Merck
AstraZeneca
Novartis
Takeda
Segment by Type
OTC
Rx Drugs

Segment by Application


Hospital
Retail Pharmacy

Consumption by Region


North America
the United States
Canada
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Central Nervous System Drugs report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source

Table of Content

1 Central Nervous System Drugs Market Overview
1.1 Product Overview and Scope of Central Nervous System Drugs
1.2 Central Nervous System Drugs Segment by Type
1.2.1 Global Central Nervous System Drugs Market Value Comparison by Type (2024-2034)
1.2.2 OTC
1.2.3 Rx Drugs
1.3 Central Nervous System Drugs Segment by Application
1.3.1 Global Central Nervous System Drugs Market Value by Application: (2024-2034)
1.3.2 Hospital
1.3.3 Retail Pharmacy
1.4 Global Central Nervous System Drugs Market Size Estimates and Forecasts
1.4.1 Global Central Nervous System Drugs Revenue 2018-2029
1.4.2 Global Central Nervous System Drugs Sales 2018-2029
1.4.3 Global Central Nervous System Drugs Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Central Nervous System Drugs Market Competition by Manufacturers
2.1 Global Central Nervous System Drugs Sales Market Share by Manufacturers (2018-2024)
2.2 Global Central Nervous System Drugs Revenue Market Share by Manufacturers (2018-2024)
2.3 Global Central Nervous System Drugs Average Price by Manufacturers (2018-2024)
2.4 Global Central Nervous System Drugs Industry Ranking 2021 VS 2022 VS 2024
2.5 Global Key Manufacturers of Central Nervous System Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Central Nervous System Drugs, Product Type & Application
2.7 Central Nervous System Drugs Market Competitive Situation and Trends
2.7.1 Central Nervous System Drugs Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Central Nervous System Drugs Players Market Share by Revenue
2.7.3 Global Central Nervous System Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Central Nervous System Drugs Retrospective Market Scenario by Region
3.1 Global Central Nervous System Drugs Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Central Nervous System Drugs Global Central Nervous System Drugs Sales by Region: 2018-2029
3.2.1 Global Central Nervous System Drugs Sales by Region: 2018-2024
3.2.2 Global Central Nervous System Drugs Sales by Region: 2024-2029
3.3 Global Central Nervous System Drugs Global Central Nervous System Drugs Revenue by Region: 2018-2029
3.3.1 Global Central Nervous System Drugs Revenue by Region: 2018-2024
3.3.2 Global Central Nervous System Drugs Revenue by Region: 2024-2029
3.4 North America Central Nervous System Drugs Market Facts & Figures by Country
3.4.1 North America Central Nervous System Drugs Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Central Nervous System Drugs Sales by Country (2018-2029)
3.4.3 North America Central Nervous System Drugs Revenue by Country (2018-2029)
3.4.4 the United States
3.4.5 Canada
3.5 Europe Central Nervous System Drugs Market Facts & Figures by Country
3.5.1 Europe Central Nervous System Drugs Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Central Nervous System Drugs Sales by Country (2018-2029)
3.5.3 Europe Central Nervous System Drugs Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 UK
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Central Nervous System Drugs Market Facts & Figures by Country
3.6.1 Asia Pacific Central Nervous System Drugs Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Central Nervous System Drugs Sales by Country (2018-2029)
3.6.3 Asia Pacific Central Nervous System Drugs Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Central Nervous System Drugs Market Facts & Figures by Country
3.7.1 Latin America Central Nervous System Drugs Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Central Nervous System Drugs Sales by Country (2018-2029)
3.7.3 Latin America Central Nervous System Drugs Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Central Nervous System Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Central Nervous System Drugs Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Central Nervous System Drugs Sales by Country (2018-2029)
3.8.3 Middle East and Africa Central Nervous System Drugs Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Central Nervous System Drugs Sales by Type (2018-2029)
4.1.1 Global Central Nervous System Drugs Sales by Type (2018-2024)
4.1.2 Global Central Nervous System Drugs Sales by Type (2024-2029)
4.1.3 Global Central Nervous System Drugs Sales Market Share by Type (2018-2029)
4.2 Global Central Nervous System Drugs Revenue by Type (2018-2029)
4.2.1 Global Central Nervous System Drugs Revenue by Type (2018-2024)
4.2.2 Global Central Nervous System Drugs Revenue by Type (2024-2029)
4.2.3 Global Central Nervous System Drugs Revenue Market Share by Type (2018-2029)
4.3 Global Central Nervous System Drugs Price by Type (2018-2029)
5 Segment by Application
5.1 Global Central Nervous System Drugs Sales by Application (2018-2029)
5.1.1 Global Central Nervous System Drugs Sales by Application (2018-2024)
5.1.2 Global Central Nervous System Drugs Sales by Application (2024-2029)
5.1.3 Global Central Nervous System Drugs Sales Market Share by Application (2018-2029)
5.2 Global Central Nervous System Drugs Revenue by Application (2018-2029)
5.2.1 Global Central Nervous System Drugs Revenue by Application (2018-2024)
5.2.2 Global Central Nervous System Drugs Revenue by Application (2024-2029)
5.2.3 Global Central Nervous System Drugs Revenue Market Share by Application (2018-2029)
5.3 Global Central Nervous System Drugs Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Biogen
6.1.1 Biogen Corporation Information
6.1.2 Biogen Description and Business Overview
6.1.3 Biogen Central Nervous System Drugs Sales, Revenue and Gross Margin (2018-2024)
6.1.4 Biogen Central Nervous System Drugs Product Portfolio
6.1.5 Biogen Recent Developments/Updates
6.2 Pfizer
6.2.1 Pfizer Corporation Information
6.2.2 Pfizer Description and Business Overview
6.2.3 Pfizer Central Nervous System Drugs Sales, Revenue and Gross Margin (2018-2024)
6.2.4 Pfizer Central Nervous System Drugs Product Portfolio
6.2.5 Pfizer Recent Developments/Updates
6.3 Teva
6.3.1 Teva Corporation Information
6.3.2 Teva Description and Business Overview
6.3.3 Teva Central Nervous System Drugs Sales, Revenue and Gross Margin (2018-2024)
6.3.4 Teva Central Nervous System Drugs Product Portfolio
6.3.5 Teva Recent Developments/Updates
6.4 Novartis
6.4.1 Novartis Corporation Information
6.4.2 Novartis Description and Business Overview
6.4.3 Novartis Central Nervous System Drugs Sales, Revenue and Gross Margin (2018-2024)
6.4.4 Novartis Central Nervous System Drugs Product Portfolio
6.4.5 Novartis Recent Developments/Updates
6.5 Johnson & Johnson
6.5.1 Johnson & Johnson Corporation Information
6.5.2 Johnson & Johnson Description and Business Overview
6.5.3 Johnson & Johnson Central Nervous System Drugs Sales, Revenue and Gross Margin (2018-2024)
6.5.4 Johnson & Johnson Central Nervous System Drugs Product Portfolio
6.5.5 Johnson & Johnson Recent Developments/Updates
6.6 EliLilly
6.6.1 EliLilly Corporation Information
6.6.2 EliLilly Description and Business Overview
6.6.3 EliLilly Central Nervous System Drugs Sales, Revenue and Gross Margin (2018-2024)
6.6.4 EliLilly Central Nervous System Drugs Product Portfolio
6.6.5 EliLilly Recent Developments/Updates
6.7 Otsuka
6.6.1 Otsuka Corporation Information
6.6.2 Otsuka Description and Business Overview
6.6.3 Otsuka Central Nervous System Drugs Sales, Revenue and Gross Margin (2018-2024)
6.4.4 Otsuka Central Nervous System Drugs Product Portfolio
6.7.5 Otsuka Recent Developments/Updates
6.8 Merck
6.8.1 Merck Corporation Information
6.8.2 Merck Description and Business Overview
6.8.3 Merck Central Nervous System Drugs Sales, Revenue and Gross Margin (2018-2024)
6.8.4 Merck Central Nervous System Drugs Product Portfolio
6.8.5 Merck Recent Developments/Updates
6.9 AstraZeneca
6.9.1 AstraZeneca Corporation Information
6.9.2 AstraZeneca Description and Business Overview
6.9.3 AstraZeneca Central Nervous System Drugs Sales, Revenue and Gross Margin (2018-2024)
6.9.4 AstraZeneca Central Nervous System Drugs Product Portfolio
6.9.5 AstraZeneca Recent Developments/Updates
6.10 Novartis
6.10.1 Novartis Corporation Information
6.10.2 Novartis Description and Business Overview
6.10.3 Novartis Central Nervous System Drugs Sales, Revenue and Gross Margin (2018-2024)
6.10.4 Novartis Central Nervous System Drugs Product Portfolio
6.10.5 Novartis Recent Developments/Updates
6.11 Takeda
6.11.1 Takeda Corporation Information
6.11.2 Takeda Central Nervous System Drugs Description and Business Overview
6.11.3 Takeda Central Nervous System Drugs Sales, Revenue and Gross Margin (2018-2024)
6.11.4 Takeda Central Nervous System Drugs Product Portfolio
6.11.5 Takeda Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Central Nervous System Drugs Industry Chain Analysis
7.2 Central Nervous System Drugs Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Central Nervous System Drugs Production Mode & Process
7.4 Central Nervous System Drugs Sales and Marketing
7.4.1 Central Nervous System Drugs Sales Channels
7.4.2 Central Nervous System Drugs Distributors
7.5 Central Nervous System Drugs Customers
8 Central Nervous System Drugs Market Dynamics
8.1 Central Nervous System Drugs Industry Trends
8.2 Central Nervous System Drugs Market Drivers
8.3 Central Nervous System Drugs Market Challenges
8.4 Central Nervous System Drugs Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Central Nervous System Drugs Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Central Nervous System Drugs Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Central Nervous System Drugs Market Competitive Situation by Manufacturers in 2022
Table 4. Global Central Nervous System Drugs Sales (K Units) of Key Manufacturers (2018-2024)
Table 5. Global Central Nervous System Drugs Sales Market Share by Manufacturers (2018-2024)
Table 6. Global Central Nervous System Drugs Revenue (US$ Million) by Manufacturers (2018-2024)
Table 7. Global Central Nervous System Drugs Revenue Share by Manufacturers (2018-2024)
Table 8. Global Market Central Nervous System Drugs Average Price (USD/Unit) of Key Manufacturers (2018-2024)
Table 9. Global Key Players of Central Nervous System Drugs, Industry Ranking, 2021 VS 2022 VS 2024
Table 10. Global Key Manufacturers of Central Nervous System Drugs, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Central Nervous System Drugs, Product Type & Application
Table 12. Global Key Manufacturers of Central Nervous System Drugs, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Central Nervous System Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Central Nervous System Drugs as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Central Nervous System Drugs Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Central Nervous System Drugs Sales by Region (2018-2024) & (K Units)
Table 18. Global Central Nervous System Drugs Sales Market Share by Region (2018-2024)
Table 19. Global Central Nervous System Drugs Sales by Region (2024-2029) & (K Units)
Table 20. Global Central Nervous System Drugs Sales Market Share by Region (2024-2029)
Table 21. Global Central Nervous System Drugs Revenue by Region (2018-2024) & (US$ Million)
Table 22. Global Central Nervous System Drugs Revenue Market Share by Region (2018-2024)
Table 23. Global Central Nervous System Drugs Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Central Nervous System Drugs Revenue Market Share by Region (2024-2029)
Table 25. North America Central Nervous System Drugs Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Central Nervous System Drugs Sales by Country (2018-2024) & (K Units)
Table 27. North America Central Nervous System Drugs Sales by Country (2024-2029) & (K Units)
Table 28. North America Central Nervous System Drugs Revenue by Country (2018-2024) & (US$ Million)
Table 29. North America Central Nervous System Drugs Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Central Nervous System Drugs Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Central Nervous System Drugs Sales by Country (2018-2024) & (K Units)
Table 32. Europe Central Nervous System Drugs Sales by Country (2024-2029) & (K Units)
Table 33. Europe Central Nervous System Drugs Revenue by Country (2018-2024) & (US$ Million)
Table 34. Europe Central Nervous System Drugs Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Central Nervous System Drugs Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Central Nervous System Drugs Sales by Region (2018-2024) & (K Units)
Table 37. Asia Pacific Central Nervous System Drugs Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific Central Nervous System Drugs Revenue by Region (2018-2024) & (US$ Million)
Table 39. Asia Pacific Central Nervous System Drugs Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Central Nervous System Drugs Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Central Nervous System Drugs Sales by Country (2018-2024) & (K Units)
Table 42. Latin America Central Nervous System Drugs Sales by Country (2024-2029) & (K Units)
Table 43. Latin America Central Nervous System Drugs Revenue by Country (2018-2024) & (US$ Million)
Table 44. Latin America Central Nervous System Drugs Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Central Nervous System Drugs Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Central Nervous System Drugs Sales by Country (2018-2024) & (K Units)
Table 47. Middle East & Africa Central Nervous System Drugs Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa Central Nervous System Drugs Revenue by Country (2018-2024) & (US$ Million)
Table 49. Middle East & Africa Central Nervous System Drugs Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Central Nervous System Drugs Sales (K Units) by Type (2018-2024)
Table 51. Global Central Nervous System Drugs Sales (K Units) by Type (2024-2029)
Table 52. Global Central Nervous System Drugs Sales Market Share by Type (2018-2024)
Table 53. Global Central Nervous System Drugs Sales Market Share by Type (2024-2029)
Table 54. Global Central Nervous System Drugs Revenue (US$ Million) by Type (2018-2024)
Table 55. Global Central Nervous System Drugs Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Central Nervous System Drugs Revenue Market Share by Type (2018-2024)
Table 57. Global Central Nervous System Drugs Revenue Market Share by Type (2024-2029)
Table 58. Global Central Nervous System Drugs Price (USD/Unit) by Type (2018-2024)
Table 59. Global Central Nervous System Drugs Price (USD/Unit) by Type (2024-2029)
Table 60. Global Central Nervous System Drugs Sales (K Units) by Application (2018-2024)
Table 61. Global Central Nervous System Drugs Sales (K Units) by Application (2024-2029)
Table 62. Global Central Nervous System Drugs Sales Market Share by Application (2018-2024)
Table 63. Global Central Nervous System Drugs Sales Market Share by Application (2024-2029)
Table 64. Global Central Nervous System Drugs Revenue (US$ Million) by Application (2018-2024)
Table 65. Global Central Nervous System Drugs Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Central Nervous System Drugs Revenue Market Share by Application (2018-2024)
Table 67. Global Central Nervous System Drugs Revenue Market Share by Application (2024-2029)
Table 68. Global Central Nervous System Drugs Price (USD/Unit) by Application (2018-2024)
Table 69. Global Central Nervous System Drugs Price (USD/Unit) by Application (2024-2029)
Table 70. Biogen Corporation Information
Table 71. Biogen Description and Business Overview
Table 72. Biogen Central Nervous System Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 73. Biogen Central Nervous System Drugs Product
Table 74. Biogen Recent Developments/Updates
Table 75. Pfizer Corporation Information
Table 76. Pfizer Description and Business Overview
Table 77. Pfizer Central Nervous System Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 78. Pfizer Central Nervous System Drugs Product
Table 79. Pfizer Recent Developments/Updates
Table 80. Teva Corporation Information
Table 81. Teva Description and Business Overview
Table 82. Teva Central Nervous System Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 83. Teva Central Nervous System Drugs Product
Table 84. Teva Recent Developments/Updates
Table 85. Novartis Corporation Information
Table 86. Novartis Description and Business Overview
Table 87. Novartis Central Nervous System Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 88. Novartis Central Nervous System Drugs Product
Table 89. Novartis Recent Developments/Updates
Table 90. Johnson & Johnson Corporation Information
Table 91. Johnson & Johnson Description and Business Overview
Table 92. Johnson & Johnson Central Nervous System Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 93. Johnson & Johnson Central Nervous System Drugs Product
Table 94. Johnson & Johnson Recent Developments/Updates
Table 95. EliLilly Corporation Information
Table 96. EliLilly Description and Business Overview
Table 97. EliLilly Central Nervous System Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 98. EliLilly Central Nervous System Drugs Product
Table 99. EliLilly Recent Developments/Updates
Table 100. Otsuka Corporation Information
Table 101. Otsuka Description and Business Overview
Table 102. Otsuka Central Nervous System Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 103. Otsuka Central Nervous System Drugs Product
Table 104. Otsuka Recent Developments/Updates
Table 105. Merck Corporation Information
Table 106. Merck Description and Business Overview
Table 107. Merck Central Nervous System Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 108. Merck Central Nervous System Drugs Product
Table 109. Merck Recent Developments/Updates
Table 110. AstraZeneca Corporation Information
Table 111. AstraZeneca Description and Business Overview
Table 112. AstraZeneca Central Nervous System Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 113. AstraZeneca Central Nervous System Drugs Product
Table 114. AstraZeneca Recent Developments/Updates
Table 115. Novartis Corporation Information
Table 116. Novartis Description and Business Overview
Table 117. Novartis Central Nervous System Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 118. Novartis Central Nervous System Drugs Product
Table 119. Novartis Recent Developments/Updates
Table 120. Takeda Corporation Information
Table 121. Takeda Description and Business Overview
Table 122. Takeda Central Nervous System Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 123. Takeda Central Nervous System Drugs Product
Table 124. Takeda Recent Developments/Updates
Table 125. Key Raw Materials Lists
Table 126. Raw Materials Key Suppliers Lists
Table 127. Central Nervous System Drugs Distributors List
Table 128. Central Nervous System Drugs Customers List
Table 129. Central Nervous System Drugs Market Trends
Table 130. Central Nervous System Drugs Market Drivers
Table 131. Central Nervous System Drugs Market Challenges
Table 132. Central Nervous System Drugs Market Restraints
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Central Nervous System Drugs
Figure 2. Global Central Nervous System Drugs Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Central Nervous System Drugs Market Share by Type in 2022 & 2029
Figure 4. OTC Product Picture
Figure 5. Rx Drugs Product Picture
Figure 6. Global Central Nervous System Drugs Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 7. Global Central Nervous System Drugs Market Share by Application in 2022 & 2029
Figure 8. Hospital
Figure 9. Retail Pharmacy
Figure 10. Global Central Nervous System Drugs Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 11. Global Central Nervous System Drugs Market Size (2018-2029) & (US$ Million)
Figure 12. Global Central Nervous System Drugs Sales (2018-2029) & (K Units)
Figure 13. Global Central Nervous System Drugs Average Price (USD/Unit) & (2018-2029)
Figure 14. Central Nervous System Drugs Report Years Considered
Figure 15. Central Nervous System Drugs Sales Share by Manufacturers in 2022
Figure 16. Global Central Nervous System Drugs Revenue Share by Manufacturers in 2022
Figure 17. The Global 5 and 10 Largest Central Nervous System Drugs Players: Market Share by Revenue in 2022
Figure 18. Central Nervous System Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 19. Global Central Nervous System Drugs Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 20. North America Central Nervous System Drugs Sales Market Share by Country (2018-2029)
Figure 21. North America Central Nervous System Drugs Revenue Market Share by Country (2018-2029)
Figure 22. the United States Central Nervous System Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 23. Canada Central Nervous System Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 24. Europe Central Nervous System Drugs Sales Market Share by Country (2018-2029)
Figure 25. Europe Central Nervous System Drugs Revenue Market Share by Country (2018-2029)
Figure 26. Germany Central Nervous System Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 27. France Central Nervous System Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 28. UK Central Nervous System Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. Italy Central Nervous System Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. Russia Central Nervous System Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Asia Pacific Central Nervous System Drugs Sales Market Share by Region (2018-2029)
Figure 32. Asia Pacific Central Nervous System Drugs Revenue Market Share by Region (2018-2029)
Figure 33. China Central Nervous System Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. Japan Central Nervous System Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. South Korea Central Nervous System Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. India Central Nervous System Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. Australia Central Nervous System Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. China Taiwan Central Nervous System Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. Indonesia Central Nervous System Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Thailand Central Nervous System Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Malaysia Central Nervous System Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Latin America Central Nervous System Drugs Sales Market Share by Country (2018-2029)
Figure 43. Latin America Central Nervous System Drugs Revenue Market Share by Country (2018-2029)
Figure 44. Mexico Central Nervous System Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Brazil Central Nervous System Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Argentina Central Nervous System Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Middle East & Africa Central Nervous System Drugs Sales Market Share by Country (2018-2029)
Figure 48. Middle East & Africa Central Nervous System Drugs Revenue Market Share by Country (2018-2029)
Figure 49. Turkey Central Nervous System Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 50. Saudi Arabia Central Nervous System Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. UAE Central Nervous System Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. Global Sales Market Share of Central Nervous System Drugs by Type (2018-2029)
Figure 53. Global Revenue Market Share of Central Nervous System Drugs by Type (2018-2029)
Figure 54. Global Central Nervous System Drugs Price (USD/Unit) by Type (2018-2029)
Figure 55. Global Sales Market Share of Central Nervous System Drugs by Application (2018-2029)
Figure 56. Global Revenue Market Share of Central Nervous System Drugs by Application (2018-2029)
Figure 57. Global Central Nervous System Drugs Price (USD/Unit) by Application (2018-2029)
Figure 58. Central Nervous System Drugs Value Chain
Figure 59. Central Nervous System Drugs Production Process
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Distributors Profiles
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries